Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Caudate Nucleus (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Caudate Nucleus (drug effects) < Caudate Nucleus (metabolism) < Caudate Nucleus (pathology)  Facettes :

List of bibliographic references indexed by Caudate Nucleus (metabolism)

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000424 (2016) Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
000658 (2015) Junchao Tong [Canada] ; Lee-Cyn Ang [Canada] ; Belinda Williams [Canada] ; Yoshiaki Furukawa [Japon] ; Paul Fitzmaurice [Nouvelle-Zélande] ; Mark Guttman [Canada] ; Isabelle Boileau [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to α-Synuclein Accumulation
001A57 (2010) Bazoumana Ouattara [Canada] ; Fabrizio Gasparini ; Marc Morissette ; Laurent Grégoire ; Pershia Samadi ; Baltazar Gomez-Mancilla ; Thérèse Di PaoloEffect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
001E02 (2009) A R Troiano [Canada] ; R. De La Fuente-Fernandez ; V. Sossi ; M. Schulzer ; E. Mak ; T J Ruth ; A J StoesslPET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
001E89 (2009) R. Nandhagopal [Canada] ; L. Kuramoto [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; J. Cragg [Canada] ; Chong S. Lee [Canada] ; J. Mckenzie [États-Unis] ; S. Mccormick [Canada] ; A. Samii [États-Unis] ; A. Troiano [Canada] ; T. J. Ruth [Canada] ; V. Sossi [Canada] ; R. De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. J. Stoessl [Canada]Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
002428 (2007) Philippe Huot [Canada] ; Martin Lévesque ; André ParentThe fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
002C55 (2004) Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
002E06 (2003) Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]Age and severity of nigrostriatal damage at onset of Parkinson's disease
003076 (2002) Frédéric Calon [Canada] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias
003A70 (1997) H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B CalneFluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
003A98 (1997) Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy
004086 (1995) H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G. C. Leger ; M. Guttman ; M. Diksic ; A. C. Evans ; A. GjeddeRegional striatal DOPA transport and decarboxylase activity in Parkinson's disease
004318 (1993) H. Hoshi [Canada] ; H. Kuwabara ; G. Léger ; P. Cumming ; M. Guttman ; A. Gjedde6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
004813 (1991) H. B. Niznik ; E. F. Fogel ; F. F. Fassos ; P. SeemanThe dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus
004855 (1990) P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.
004C46 (1988) S. J. Kish ; K. Shannak ; O. HornykiewiczUneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Caudate Nucleus (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Caudate Nucleus (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Caudate Nucleus (metabolism)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022